Hot Flashes Concept

subject area of

• A Pilot, 8-Week, Placebo Lead-In Trial of Quetiapine Extended Release for Depression in Midlife Women  Academic Article
• Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer  Academic Article
• Black Cohosh and Breast Cancer  Academic Article
• Challenges and Opportunities to Manage Depression During the Menopausal Transition and Beyond  Academic Article
• Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer.  Academic Article
• Cognitive-behavioral, behavioral, and mindfulness-based therapies for menopausal depression: A review  Academic Article
• Cognitive–behavioral group treatment for menopausal symptoms: a pilot study  Academic Article
• Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor–Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial  Academic Article
• Comparative efficacy and safety of estradiol transdermal preparations for the treatment of vasomotor symptoms in postmenopausal women  Academic Article
• Comparing Interventions for Management of Hot Flashes in Patients With Breast and Prostate Cancer: A Systematic Review With Meta-Analyses  Academic Article
• Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses  Academic Article
• Conventional and Complementary Therapies: A Tale of Two Research Standards?  Academic Article
• Endocrine symptoms to predict risk of recurrence?  Academic Article
• Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial  Academic Article
• Flax and Breast Cancer  Academic Article
• Identifying subpopulations for subgroup analysis in a longitudinal clinical trial  Academic Article
• Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial  Academic Article
• Knowledge and Attitude towards Menopause and Hormone Replacement Therapy in Chinese Women  Academic Article
• Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled Trial  Academic Article
• Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors  Academic Article
• Non-Hormonal Treatment Strategies for Vasomotor Symptoms  Academic Article
• ONS Guidelines™ for Cancer Treatment–Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer  Academic Article
• Objective and subjective vasomotor symptom outcomes in the CBT-Meno randomized controlled trial  Academic Article
• The Midlife Transition, Depression, and Its Clinical Management  Academic Article
• The effect of serotonin reuptake inhibitors on the vaginal epithelium in postmenopausal women  Academic Article
• The importance of cognitive and behavioral factors in the experience and maintenance of menopausal symptoms  Academic Article
• Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.  Academic Article
• Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist  Academic Article
• Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial  Academic Article